CenTrial Logo

Is Aspirin as Effetive as Heparin in Reducing Blood Clots after Bone Fracture?


Is aspirin as effective as heparin in reducing blood clots after bone fracture?

Are you a physically active individual? Have you ever had a bone fracture after a fall or an accident? A recent clinical trial was conducted to compare the effects of aspirin versus heparin on reducing the risk of blood clots after a fracture.

A fracture is a partial or complete break in the bone. A bone fracture happens when something hits your bone with enough force not only to damage it but to break it in at least one place.

Thromboprophylaxis is a medical term that refers to the prevention of blood clots. Fractures, particularly those that require surgery, can increase the risk of developing blood clots, which can be dangerous or even life-threatening. Blood clots can travel throughout the body and can result in heart attack, stroke, lung failure, and kidney failure.

Heparin is usually used to prevent blood clots after a fracture however; it has several side effects such as an allergic reaction and excessive bleeding. Additionally, it can only be used in the form of an injection. Aspirin has recently been introduced as an alternative and can be given in the form of a tablet. So, a clinical trial was conducted to determine if aspirin was indeed safe and effective in reducing blood clots in fracture patients.

The clinical study involved 12,211 patients who had a fracture that required surgery. The patients were randomly assigned to receive either aspirin or heparin for preventing blood clots. The patients were followed for 90 days to determine if they developed blood clots.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me
The results of the clinical trial showed that 47 out of 6101 patients in the aspirin group died due to blood clots while 45 out of 6110 patients in the heparin group passed away due to blood clots. This showed that there was no significant difference between the two medicines and both were equally effective in reducing blood clots in fracture patients.
The clinical study also found that aspirin did not increase the risk of side effects such as bleeding in fracture patients. 

Overall, the clinical study provides important information for healthcare providers who treat patients with fractures. Both aspirin and heparin are safe and effective options for reducing blood clots after a fracture.

It is also important for patients to follow the advice of their healthcare provider before starting either medicine for the prevention of blood clots after fractures.

In conclusion, this clinical trial provides crucial knowledge for doctors and patients regarding the use of aspirin and heparin for reducing blood clots after a fracture. Both medications are equally safe and potent for preventing blood clots. The trial concluded that aspirin can be used as an alternative to heparin in the prevention of blood clots in fracture patients, thus avoiding exposure to heparin's side effects.

Share this article with a friend:

Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

Signup to be notified of clinical trials near you that match your condition

Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.

This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.